Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cancer Vaccines01:30

Cancer Vaccines

319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations.

JCI insight·2026
Same author

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience.

Journal of the National Cancer Institute·2025
Same author

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.

Cancer research communications·2025
Same author

Body composition as a potential biomarker of recurrence risk in patients with triple-negative breast cancer.

Breast cancer research and treatment·2025
Same author

Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer.

Endocrinology·2025
Same author

Racism, discrimination, medical mistrust, stigma, and lung cancer screening: a scoping review.

Ethnicity & health·2025

Related Experiment Video

Updated: May 22, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K

Metastatic Head and Neck Cancer: Immunotherapy and Beyond.

Kirsten V Nguyen1, Cody M Lebeck Lee2, Jennifer H Choe3

  • 1Vanderbilt University, School of Medicine, Nashville, TN.

Seminars in Radiation Oncology
|March 16, 2025
PubMed
Summary

Immunotherapy offers improved outcomes for head and neck cancer patients, but response rates are suboptimal. Future research focuses on novel targets and platforms to enhance treatment efficacy in metastatic and recurrent settings.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

242
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K

Related Experiment Videos

Last Updated: May 22, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

242
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K

Area of Science:

  • Oncology
  • Immunology

Background:

  • Head and neck cancer accounts for a significant number of diagnoses and deaths annually.
  • Metastatic disease represents a substantial proportion of head and neck cancer cases.
  • Immunotherapy has emerged as a key treatment modality for metastatic and recurrent head and neck malignancies.

Purpose of the Study:

  • To review the current landscape of immunotherapies for head and neck cancers.
  • To explore future directions and novel therapeutic strategies in head and neck cancer immunotherapy.
  • To identify emerging targets and platforms for improved treatment outcomes.

Main Methods:

  • Literature review of current immunotherapy treatments.
  • Analysis of response rates and outcomes in head and neck cancer patients.
  • Discussion of ongoing research and future therapeutic avenues.

Main Results:

  • Immunotherapy has improved outcomes but exhibits suboptimal response rates (13%-20%).
  • Durable responses are observed in a subset of patients.
  • Current treatments are a cornerstone but leave room for improvement.

Conclusions:

  • Immunotherapy is a vital component of head and neck cancer treatment, yet challenges remain.
  • Further investigation into novel targets and therapeutic platforms is crucial.
  • Future strategies aim to enhance response rates and long-term efficacy for patients with advanced disease.